[1]
“Tocilizumab As A Potential Treatment for SARS-CoV2 Pneumonia in Cancer Patients: A Case Report of A Patient with Clinical-Radiological Dissociated Response”, acmcr, vol. 4, no. 5, pp. 733–737, Sep. 2020, Accessed: Sep. 11, 2026. Available: https://fortunejournals.org/ojs/index.php/acmcr/article/view/22376